Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raj K Shirumalla

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|May 10, 2008
Ceramide kinase: a potential anti-inflammatory target?Shweta Saxena, Manish Banerjee, Raj K Shirumalla, et al.
Current Rheumatology Reviews|January 4, 2024
New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: OverviewPriyanka Kumari, Raj K Shirumalla, Vijay Bhalla, et al.
European Journal of Pharmacology|August 11, 2006
Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious ratsKrishna S Naruganahalli, Raj K Shirumalla, Vimal Bansal, et al.
European Journal of Pharmacology|March 5, 2011
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonistSuman Gupta, Shivani Malhotra, Sandeep Sinha, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Investigational Drugs (London, England : 2000)|May 10, 2008
Ceramide kinase: a potential anti-inflammatory target?Shweta Saxena, Manish Banerjee, Raj K Shirumalla, et al.
Current Rheumatology Reviews|January 4, 2024
New Emerging Aspect of Herbal Extracts for the Treatment of Osteoporosis: OverviewPriyanka Kumari, Raj K Shirumalla, Vijay Bhalla, et al.
European Journal of Pharmacology|August 11, 2006
Ranbezolid, a novel oxazolidinone antibacterial: in vivo characterisation of monoamine oxidase inhibitory potential in conscious ratsKrishna S Naruganahalli, Raj K Shirumalla, Vimal Bansal, et al.
European Journal of Pharmacology|March 5, 2011
Pharmacodynamic and pharmacokinetic profile of RBx 343E48F0: a novel, long acting muscarinic receptor antagonistSuman Gupta, Shivani Malhotra, Sandeep Sinha, et al.
Pageof 1